SMART (Simultaneous Modulated Accelerated Radiation Therapy) boost: A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 1, 1999, Pages 21-32

  Butler, E Brian ^a   Teh, Bin S ^a   Grant III, Walter H ^a   Uhl, Barry M ^a   Kuppersmith, Ronald B ^b   Chiu, J Kam ^a   Donovan, Donald T ^b   Woo, Shiao Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Head and neck carcinoma; Intensity modulated radiotherapy; SMART boost

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; DOSIMETRY; FEMALE; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; LUNG METASTASIS; MALE; MEDICARE; MUCOSA INFLAMMATION; PARENTERAL NUTRITION; PHARYNGITIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; SCORING SYSTEM; SIMULTANEOUS MODULATED ACCELERATED RADIATION THERAPY; TREATMENT OUTCOME; WEIGHT REDUCTION; XEROSTOMIA;

AGED; CARCINOMA, ADENOID CYSTIC; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMOBILIZATION; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; TIME FACTORS;

EID: 0032790945     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00101-7     Document Type: Article

References (19)

1. Fowler J.F. The linear-quadratic formula and program in fractionated radiotherapy. Br J Radiol. 62:1989;679-694.
2. Peters L.J., Ang K.K., Mames H.D. Jr. Accelerated fractionation in the radiation treatment of head and neck cancer. Acta Oncol. 27:1988;185-194.
3. Withers H.R., Taylor J.M.G., Macejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
4. Sladowski K., Macejewski B., Pileski B., Swiatmicka J., Golen M., Przeorek W. Randomized clinical trial of accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on therapy toxicity. Radiother Oncol. 40:1996;S40.
5. Overgaard J., Sand Hansen H., Sapru W., Overgaard M., Grau C., Jergensen K., Bastholt L., Hansen O., Specht L., Berthelsen A., Pedersen M. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week - preliminary report from DAHANCA 6 and 7 trial. Radiother Oncol. 40:1996;531.
6. Jackson S.M., Weir L.M., Hay J.H., Tsang V.H.Y., Durham J.S. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 43:1997;39-46.
7. Ang K.K., Peters L.J., Weber R. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 19:1990;1339-1345.
8. Grant W. Experience in intensity modulated beam delivery. Editors: Mackie TR, Palta JR. Teletherapy present and future. 1996;793-803 Advanced Medical Publishing, Madison, WI.
9. Woo S.Y., Grant W.H., Bellezza D., Grossman R., Gildenberg P., Carpenter L.S., Carol M., Butler E.B. A comparison of intensity modulated conformal therapy with a conventional external beam stereotactic radiosurgery system for the treatment of single and multiple intracranial lesions. Int J Radiat Oncol Biol Phys. 35:1996;593-597.
10. Hornsberger HR. Imaging of the suprahyoid and infrahyoid neck. In: Harnsberger HR. Head and neck imaging. St. Louis, MO; Year Book Medical Publishers, 1990:1-224.
11. Slevin N.J., Vasanthan S., Dougal M. Relative clinical influence of tumor dose versus dose per fraction on the occurance of late normal tissue morbidity following larynx radiotherapy. Int J Radiat Oncol Biol Phys. 25:1993;23-28.
12. Harwood A.R. Cancer of the larynx. The Toronto experience. J Laryngol. 11:1982;1-21.
13. Saunders M.I., Dische S., Grosch E.J., Fermont D.C., Ashford R.F.U., Maher E.J., Makepeace A.R. Experience with CHART. Int J Radiat Oncol Biol Phys. 21:(3):1991;871-878.
14. Horiot J.C., Le Fur R., N'Guyen T., Chenal C., Schraub S., Alfonsi S., Gardani G., Van Den Bogaert W., Danczak S., Bolla M., Van Glabbeke M., De Pauw M. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma Final analysis of a randomized trial of the EORTC Cooperative group of radiotherapy . Radiother Oncol. 25:1992;231-241.
15. Ang K.K. Accelerated fractionation What is the price for speeding? Radiother Oncol. 44:1997;97-99.
16. Johnson J.T., Ferretti G.A., Nethery W.J., Valdez I.H., Fox P.C., Ng D., Muscoplat C.C., Gallagher S.C. Oral pilocarpine for postirradiation xerostomia in patients with head and neck cancer. N Engl J Med. 329:1993;390-395.
17. Bataini J.P., Bernier J., Jaulerry C., Brunin F., Pontvert D., Lave C. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy. Int J Radiat Oncol Biol Phys. 13:1987;817-824.
18. Carol M., Grant W.H., Bleier A.R., Kania A.A., Targovnik H.S., Butler E.B., Woo S.Y. The field-matching problem as it applies to the peacock three dimensional conformal system for intensity modulation. Int J Radiat Oncol Biol Phys. 34:1996;183-187.
19. Pfister D.G., Ruchlin H.S., Elkin E.B. Economic consideration in the care of patients with head and neck malignancies. Curr Opin Oncol. 9:1997;241-246.